DBV Technologies | DBVT - Market Capitalization


DBV Technologies reported $807M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 290M 51M Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025